-
The Food and Drug Administration said it's gotten over 100 complaints linked to the General Mills cereal this year. General Mills said its own investigation hasn't found evidence of consumer illness.
-
A multistate outbreak of norovirus illnesses linked to raw oysters from Canada is under investigation in 13 states by the FDA.
-
Nearly three years after Florida lawmakers approved a plan to import cheaper prescription drugs from Canada, Gov. Ron DeSantis expressed frustration Tuesday that the plan remains stalled in Washington, D.C.
-
People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first.
-
No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect.
-
Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.
-
The fight between Florida Gov. DeSantis and the federal government over COVID-19 hit a new chord this week.
-
Monoclonal antibody sites to treat COVID-19 throughout Florida are closed until further notice.The U.S. Food and Drug Administration has removed authorization for the Regeneron and Eli Lilly monoclonal antibody treatments.
-
Florida monoclonal antibody sites have closed following the U.S. Food and Drug Administration’s announcement that the treatments don’t work against the COVID omicron variant.
-
The authorization comes in the midst of an explosion of COVID-19 cases nationwide driven by the omicron variant — a surge that has brought a spike in pediatric hospitalizations.
-
The new at-home COVID treatment is currently available in limited quantities to states and territories. Some states will get as few as 120 courses of treatment at first.
-
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.